000469509 000__ 01659cam\a2200349\a\4500
000469509 001__ 469509
000469509 005__ 20210513163602.0
000469509 006__ m\\\\\o\\d\\\\\\\\
000469509 007__ cr\cn|||||||||
000469509 008__ 120529s2012\\\\dcua\\\\ob\\\\000\0\eng\d
000469509 010__ $$z  2012021854
000469509 020__ $$z9780309218139
000469509 020__ $$z9780309218146
000469509 035__ $$a(CaPaEBR)ebr10606354
000469509 035__ $$a(OCoLC)811594850
000469509 040__ $$aCaPaEBR$$cCaPaEBR
000469509 05014 $$aRM301.27$$b.E84 2012eb
000469509 24500 $$aEthical and scientific issues in studying the safety of approved drugs$$h[electronic resource] /$$cCommittee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
000469509 260__ $$aWashington, D.C. :$$bNational Academies Press,$$cc2012.
000469509 300__ $$axvi, 275 p. :$$bill.
000469509 504__ $$aIncludes bibliographical references.
000469509 506__ $$aAccess limited to authorized users.
000469509 650_0 $$aDrugs$$xTesting$$xMoral and ethical aspects$$zUnited States.
000469509 650_0 $$aClinical trials$$xMoral and ethical aspects$$zUnited States.
000469509 650_0 $$aDrug approval$$zUnited States.
000469509 655_7 $$aElectronic books.$$2lcsh
000469509 7102_ $$aInstitute of Medicine (U.S.).$$bCommittee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
000469509 7102_ $$aInstitute of Medicine (U.S.).$$bBoard on Population Health and Public Health Practice.
000469509 7102_ $$aNational Academies Press (U.S.)
000469509 852__ $$bebk
000469509 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10606354$$zOnline Access
000469509 909CO $$ooai:library.usi.edu:469509$$pGLOBAL_SET
000469509 980__ $$aEBOOK
000469509 980__ $$aBIB
000469509 982__ $$aEbook
000469509 983__ $$aOnline